P. Rao

Edward E Knaus, Praveen Rao, E. Knaus, 2008, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

Synthesis and biological evaluation of isoxazolo[4,5-d]pyridazin-4-(5H)-one analogues as potent anti-inflammatory agents.

C. Velázquez-Martínez, P. Rao, Sarthak Jain, 2012, Bioorganic & medicinal chemistry.

Design and syntheses of diarylisoxazoles: Novel inhibitors of cyclooxygenase‐2 (COX‐2) with analgesic‐antiinflammatory activity

E. Knaus, P. Rao, A. G. Habeeb, 2000 .

A-ring substituted 17β-arylsulfonamides of 17β-aminoestra-1,3,5(10)-trien-3-ol as highly potent reversible inhibitors of steroid sulfatase.

Scott D. Taylor, Yaser A. Mostafa, P. Rao, 2015, Bioorganic & medicinal chemistry.

6-Alkyl, alkoxy, or alkylthio-substituted 3-(4-methanesulfonylphenyl)-4-phenylpyran-2-ones: a novel class of diarylheterocyclic selective cyclooxygenase-2 inhibitors.

Mohsen Amini, Huiying Li, M. Amini, 2003, Bioorganic & medicinal chemistry letters.

Design, synthesis, and biological evaluation of linear 1-(4-, 3- or 2-methylsulfonylphenyl)-2-phenylacetylenes: a novel class of cyclooxygenase-2 inhibitors.

Qiao-Hong Chen, E. Knaus, P. Rao, 2005, Bioorganic & medicinal chemistry.

Design and synthesis of (E)-1,1,2-triarylethenes: novel inhibitors of the cyclooxygenase-2 (COX-2) isozyme.

M. J. Uddin, R. McDonald, E. Knaus, 2005, Bioorganic & medicinal chemistry letters.

Investigating the binding interactions of the anti-Alzheimer's drug donepezil with CYP3A4 and P-glycoprotein.

A. McEneny-King, A. Edginton, P. Rao, 2015, Bioorganic & medicinal chemistry letters.

Synthesis and biological evaluation of 3,4-diphenyl-1,2,5-oxadiazole-2-oxides and 3,4-diphenyl-1,2,5-oxadiazoles as potential hybrid COX-2 inhibitor/nitric oxide donor agents.

R. McDonald, E. Knaus, P. Rao, 2005, Bioorganic & medicinal chemistry.

Positively Charged Chitosan and N-Trimethyl Chitosan Inhibit Aβ40 Fibrillogenesis.

D. Du, E. Wojcikiewicz, B. Ojha, 2015, Biomacromolecules.

Histone Demethylase KDM5B as a Therapeutic Target for Cancer Therapy

J. Kolesar, Mahadev Rao, G. Shenoy, 2020, Cancers.

Amyloid cascade in Alzheimer's disease: Recent advances in medicinal chemistry.

T. Mohamed, P. Rao, A. Shakeri, 2016, European journal of medicinal chemistry.

Design, syntheses, and evaluation of novel 1,1‐dihalo‐2,3‐diphenylcyclopropanes as potential cyclooxygenase‐2 (COX‐2) inhibitors with analgesic‐antiinflammatory activity

E. Knaus, P. Rao, A. G. Habeeb, 2002 .

Synthesis and biological evaluation of 1,3-diphenylprop-2-en-1-ones possessing a methanesulfonamido or an azido pharmacophore as cyclooxygenase-1/-2 inhibitors.

A. Zarghi, F. Shirazi, Tannaz Zebardast, 2006, Bioorganic & medicinal chemistry.

Apigenin directly interacts with and inhibits topoisomerase 1 to upregulate CD26/DPP4 on colorectal carcinoma cells

J. Blay, J. Fux, Émilie C. Lefort, 2022, Frontiers in Pharmacology.

ROLE OF UHRF1 IN MALIGNANCY AND ITS FUNCTION AS A THERAPEUTIC TARGET FOR MOLECULAR DOCKING TOWARDS THE SRA DOMAIN.

Mahadev Rao, R. Pestell, Sophia M George, 2019, The international journal of biochemistry & cell biology.

Design, synthesis and structure-activity relationship (SAR) studies of 2,4-disubstituted pyrimidine derivatives: dual activity as cholinesterase and Aβ-aggregation inhibitors.

Jerry Yang, T. Mohamed, P. Rao, 2011, Bioorganic & medicinal chemistry.

Design and synthesis of new rofecoxib analogs as selective cyclooxygenase-2 ( COX-2 ) inhibitors : Replacement of the methanesulfonyl pharmacophore by an N-acetylsulfon-amido bioisostere

A. Zarghi, Knaus, P. Rao, 2007 .

Investigating the binding interactions of galantamine with β-amyloid peptide.

T. Mohamed, P. Rao, Wesseem Osman, 2013, Bioorganic & medicinal chemistry letters.

Synthesis and biological evaluation of 1,3-diphenylprop-2-yn-1-ones as dual inhibitors of cyclooxygenases and lipoxygenases.

Qiao-Hong Chen, E. Knaus, P. Rao, 2005, Bioorganic & medicinal chemistry letters.

Design of acyclic triaryl olefins: a new class of potent and selective cyclooxygenase-2 (COX-2) inhibitors.

M. J. Uddin, E. Knaus, P. Rao, 2004, Bioorganic & medicinal chemistry letters.

Synthesis and biological evaluation of linear phenylethynylbenzenesulfonamide regioisomers as cyclooxygenase-1/-2 (COX-1/-2) inhibitors.

Qiao-Hong Chen, E. Knaus, P. Rao, 2006, Bioorganic & medicinal chemistry.

Design and synthesis of 4,5-diphenyl-4-isoxazolines: novel inhibitors of cyclooxygenase-2 with analgesic and antiinflammatory activity.

E. Knaus, P. Rao, P. N. Praveen Rao, 2001, Journal of medicinal chemistry.

Design and synthesis of celecoxib and rofecoxib analogues as selective cyclooxygenase-2 (COX-2) inhibitors: replacement of sulfonamide and methylsulfonyl pharmacophores by an azido bioisostere.

E. Knaus, P. Rao, P. N. Praveen Rao, 2001, Journal of medicinal chemistry.

Apricoxib, a COX-2 inhibitor for the potential treatment of pain and cancer.

R. Grover, P. Rao, 2009, IDrugs : the investigational drugs journal.

A-ring substituted 17β-arylsulfonamides of 17β-aminoestra-1,3,5(10)-trien-3-ol as highly potent reversible inhibitors of steroid sulfatase.

Scott D. Taylor, Yaser A. Mostafa, P. Rao, 2015, Bioorganic & medicinal chemistry.

Design and synthesis of (Z)-1,2-diphenyl-1-(4-methanesulfonamidophenyl)alk-1-enes and (Z)-1-(4-azidophenyl)-1,2-diphenylalk-1-enes: novel inhibitors of cyclooxygenase-2 (COX-2) with anti-inflammatory and analgesic activity.

E. Knaus, P. Rao, M. Uddin, 2005, Bioorganic & medicinal chemistry.